Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2018-09-30
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Currently, the data collected by national audit programmes are concentrated on what can be termed 'process or process of care' data. The utility of these data are in the ability to audit the care received by stroke survivors on stroke units against evidenced standards for care, thus ensuring evidence based practice. Nevertheless, process of care is only one form of measuring stroke unit care and the audit programmes collect some limited functional status data, data relating to risk-factor co-morbidities and treatment received data. Therefore, the scope of this study is to build on the minimum data set currently collected and to collect post-stroke data in domains not currently collected.
The International Consortium for Health Outcomes Measurement (ICHOM) takes important steps to collect data outside of process of care data such as a Patient Reported outcome data in their minimum outcome data set for stroke \[currently under review\].. Nevertheless, the ICHOM doesn't currently advocate the specific collection of data relating to cognitive impairment or emotional problems secondary to stroke. It is in these important aspects that this study will augment the data set currently advocated by ICHOM to collect data in the areas of cognitive impairment and emotional problems secondary to stroke.
Therefore, the aim of this study is to quantify the prevalence of morbidity at six months post-stroke.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
NCT05645081
Liverpool-Heart and BRain Project Stroke Cohort
NCT05132465
Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
NCT05643001
Study of Factors Influencing Post-stroke Dementia
NCT01330160
Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort
NCT01363856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cerebral Infarct (ICD I63) \[1\]
* Intracerebral Haemorrhage (ICD I61) \[1\]
* Stroke, not specified as haemorrhage or infarction (ICD I64) \[1\]
* 18 years of age or older (≥ 18 years old)
* Received a clinically confirmed diagnosis of stroke within the previous 14 days (Stroke diagnosis ≤ 14 days)
Exclusion Criteria
* Transient Ischaemic Attack (ICD G45) \[1\]
* Subarachnoid Haemorrhage (ICD I60) \[1\]
* Any condition defined under ICD G93 e.g. Anoxic brain damage \[1\]
* Patients receiving or eligible for Palliative Care.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aneurin Bevan University Health Board
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Jonathan Hewitt
Clinical Senior Lecturer & Honorary Consultant Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Hewitt, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
Cardiff University & Aneurin Bevan University Health Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ysbyty Ystrad Fawr
Ystrad Mynach, Caerphilly, United Kingdom
Royal Gwent Hospital
Newport, Gwent, United Kingdom
Prince Charles Hospital
Merthyr Tydfil, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Smith A, Bains N, Copeland L, Pennington A, Carter B, Hewitt J. Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study. JMIR Res Protoc. 2020 Jun 17;9(6):e15851. doi: 10.2196/15851.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03 ABUHB
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SP06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.